131 related articles for article (PubMed ID: 9851801)
1. Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro.
Leitch IM; Boura AL; Botti C; Read MA; Walters WA; Smith R
J Clin Endocrinol Metab; 1998 Dec; 83(12):4510-3. PubMed ID: 9851801
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-releasing hormone-induced vasodilatation in the human fetal placental circulation.
Clifton VL; Read MA; Leitch IM; Boura AL; Robinson PJ; Smith R
J Clin Endocrinol Metab; 1994 Aug; 79(2):666-9. PubMed ID: 8045990
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3',5'-monophosphate-mediated pathway.
Clifton VL; Read MA; Leitch IM; Giles WB; Boura AL; Robinson PJ; Smith R
J Clin Endocrinol Metab; 1995 Oct; 80(10):2888-93. PubMed ID: 7559870
[TBL] [Abstract][Full Text] [Related]
4. Fetal placental vascular responses to corticotropin-releasing hormone in vitro. Effects of variation in oxygen tension.
Donoghue JF; Leitch IM; Boura AL; Walters WA; Giles WB; Smith R; Read MA
Placenta; 2000 Sep; 21(7):711-7. PubMed ID: 10985975
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide regulation of corticotropin-releasing hormone release from the human perfused placenta in vitro.
Roe CM; Leitch IM; Boura AL; Smith R
J Clin Endocrinol Metab; 1996 Feb; 81(2):763-9. PubMed ID: 8636301
[TBL] [Abstract][Full Text] [Related]
6. D-amino acid-substituted analogs of corticotropin-releasing hormone (CRH) and urocortin with selective agonist activity at CRH1 and CRH2beta receptors.
Wei ET; Thomas HA; Christian HC; Buckingham JC; Kishimoto T
Peptides; 1998; 19(7):1183-90. PubMed ID: 9786168
[TBL] [Abstract][Full Text] [Related]
7. Adrenocorticotropin causes vasodilatation in the human fetal-placental circulation.
Clifton VL; Read MA; Boura AL; Robinson PJ; Smith R
J Clin Endocrinol Metab; 1996 Apr; 81(4):1406-10. PubMed ID: 8636342
[TBL] [Abstract][Full Text] [Related]
8. Short-term effects of glucocorticoids in the human fetal-placental circulation in vitro.
Clifton VL; Wallace EM; Smith R
J Clin Endocrinol Metab; 2002 Jun; 87(6):2838-42. PubMed ID: 12050259
[TBL] [Abstract][Full Text] [Related]
9. Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro.
Petraglia F; Florio P; Benedetto C; Marozio L; Di Blasio AM; Ticconi C; Piccione E; Luisi S; Genazzani AR; Vale W
J Clin Endocrinol Metab; 1999 Apr; 84(4):1420-3. PubMed ID: 10199789
[TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands.
Krause K; Schnitger A; Fimmel S; Glass E; Zouboulis CC
Horm Metab Res; 2007 Feb; 39(2):166-70. PubMed ID: 17326013
[TBL] [Abstract][Full Text] [Related]
11. U46619-mediated vasoconstriction of the fetal placental vasculature in vitro in normal and hypertensive pregnancies.
Read MA; Leitch IM; Giles WB; Bisits AM; Boura AL; Walters WA
J Hypertens; 1999 Mar; 17(3):389-96. PubMed ID: 10100077
[TBL] [Abstract][Full Text] [Related]
12. CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators.
Wiley KE; Davenport AP
Br J Pharmacol; 2004 Oct; 143(4):508-14. PubMed ID: 15381637
[TBL] [Abstract][Full Text] [Related]
13. Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins.
Grammatopoulos DK; Randeva HS; Levine MA; Katsanou ES; Hillhouse EW
Mol Endocrinol; 2000 Dec; 14(12):2076-91. PubMed ID: 11117536
[TBL] [Abstract][Full Text] [Related]
14. Effect of inhibition of nitric oxide synthase and guanylate cyclase on hydralazine-induced vasodilatation of the human fetal placental circulation.
Leitch IM; Read MA; Boura AL; Walters WA
Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):615-22. PubMed ID: 7529152
[TBL] [Abstract][Full Text] [Related]
15. Corticotropin-releasing hormone and urocortin induce secretion of matrix metalloproteinase-9 (MMP-9) without change in tissue inhibitors of MMP-1 by cultured cells from human placenta and fetal membranes.
Li W; Challis JR
J Clin Endocrinol Metab; 2005 Dec; 90(12):6569-74. PubMed ID: 16174714
[TBL] [Abstract][Full Text] [Related]
16. Preeclampsia is associated with impaired regulation of the placental nitric oxide-cyclic guanosine monophosphate pathway by corticotropin-releasing hormone (CRH) and CRH-related peptides.
Karteris E; Vatish M; Hillhouse EW; Grammatopoulos DK
J Clin Endocrinol Metab; 2005 Jun; 90(6):3680-7. PubMed ID: 15784708
[TBL] [Abstract][Full Text] [Related]
17. Localization and characterization of urocortin during human pregnancy.
Clifton VL; Gu Q; Murphy VE; Schwartz J; Madsen G; Smith R
Placenta; 2000 Nov; 21(8):782-8. PubMed ID: 11095927
[TBL] [Abstract][Full Text] [Related]
18. Vasodilatory response of fetoplacental vasculature to adrenomedullin after constriction with the thromboxane sympathomimetic U46619.
Hoeldtke NJ; Wagner RK; Calhoun BC; Hume RF
Am J Obstet Gynecol; 2000 Dec; 183(6):1573-8. PubMed ID: 11120530
[TBL] [Abstract][Full Text] [Related]
19. Urocortin-induced relaxation in the human internal mammary artery.
Chen ZW; Huang Y; Yang Q; Li X; Wei W; He GW
Cardiovasc Res; 2005 Mar; 65(4):913-20. PubMed ID: 15721872
[TBL] [Abstract][Full Text] [Related]
20. Characterising the corticotropin-releasing hormone (CRH) receptors mediating CRH and urocortin actions during human pregnancy and labour.
Hillhouse EW; Grammatopoulos DK
Stress; 2001 Dec; 4(4):235-46. PubMed ID: 22432144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
